Cronos Group Inc.

Healthcare

NASDAQ:CRON · NASDAQ Global Market

Market Cap $1.02B Beta 1.25 P/E (TTM) -494.6

$2.68 -2.55%

-$0.07 today

52W Low $1.84High $3.43

Vol 0.85M · Avg 1.52M

EPS (TTM)-$0.01

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+38.86%

Period High

$3.27

Period Low

$1.86

Latest

$2.68

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Nurix Therapeutics, Inc.

NASDAQ:NRIX

$1.47B

Rapport Therapeutics, Inc. Common Stock

NASDAQ:RAPP

$1.40B

IRadimed Corporation

NASDAQ:IRMD

$1.20B

Collegium Pharmaceutical, Inc.

NASDAQ:COLL

$1.12B

Xencor, Inc.

NASDAQ:XNCR

$914.17M

Pacira BioSciences, Inc.

NASDAQ:PCRX

$904.31M

Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

$885.83M

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

$827.07M

BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

$620.83M

Embecta Corp.

NASDAQ:EMBC

$183.92M

What is the latest CRON filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does CRON have?

Intrinsic Alpha currently shows 20 recent filings for CRON.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.